Sequential contralateral facial nerve palsies following COVID-19 vaccination first and second doses
- PMID: 34281950
- PMCID: PMC8291314
- DOI: 10.1136/bcr-2021-243829
Sequential contralateral facial nerve palsies following COVID-19 vaccination first and second doses
Abstract
A 61-year-old man presented to the ENT emergency clinic with a history of unilateral facial nerve palsy occurring shortly after each dose of the Pfizer-BioNTech COVID-19 vaccine. The first episode developed 5 hours after administration of the first dose and the second 2 days after administration of the second dose. Investigations at initial presentation to the emergency department were unremarkable, and the patient was diagnosed with Bell's palsy on both occasions. We describe the first case of Bell's palsy occurring after each dose of any UK-approved COVID-19 vaccine. Single episodes of unilateral facial nerve palsies have been reported in clinical trials and in subsequent case reports. There has been no evidence, however, of an episode after each dose. We also describe the earliest onset of symptoms from timing of administration of the vaccine, further suggesting the Bell's palsy was associated with the vaccine.
Keywords: COVID-19; cranial nerves; otolaryngology / ENT; safety; vaccination/immunisation.
© BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Hypoglossal nerve palsy after SARS-CoV-2 vaccination - report of two cases.BMC Neurol. 2022 Nov 9;22(1):416. doi: 10.1186/s12883-022-02929-2. BMC Neurol. 2022. PMID: 36352369 Free PMC article.
-
[Bell's Palsy Secondary to COVID-19 Vaccine Pfizer: Case report].Rev Med Inst Mex Seguro Soc. 2022 Mar 1;60(2):224-228. Rev Med Inst Mex Seguro Soc. 2022. PMID: 35759681 Free PMC article. Spanish.
-
Safety of COVID-19 vaccination and acute neurological events: A self-controlled case series in England using the OpenSAFELY platform.Vaccine. 2022 Jul 30;40(32):4479-4487. doi: 10.1016/j.vaccine.2022.06.010. Epub 2022 Jun 7. Vaccine. 2022. PMID: 35715350 Free PMC article.
-
Corticosteroid Use in Otolaryngology: Current Considerations During the COVID-19 Era.Otolaryngol Head Neck Surg. 2022 Nov;167(5):803-820. doi: 10.1177/01945998211064275. Epub 2021 Dec 7. Otolaryngol Head Neck Surg. 2022. PMID: 34874793 Review.
-
Bell's Palsy After Vaccination Against Covid-19: A Systematic Review and Meta-analysis.Otolaryngol Head Neck Surg. 2023 Nov;169(5):1114-1121. doi: 10.1002/ohn.385. Epub 2023 Jun 5. Otolaryngol Head Neck Surg. 2023. PMID: 37272720 Review.
Cited by
-
Bell's Palsy, an Adverse Event Following COVID Vaccines.Iran J Otorhinolaryngol. 2024 Jul;36(4):527-535. doi: 10.22038/IJORL.2024.69721.3364. Iran J Otorhinolaryngol. 2024. PMID: 39015690 Free PMC article. Review.
-
Cardiac and Neurological Complications Post COVID-19 Vaccination: A Systematic Review of Case Reports and Case Series.Vaccines (Basel). 2024 May 24;12(6):575. doi: 10.3390/vaccines12060575. Vaccines (Basel). 2024. PMID: 38932303 Free PMC article. Review.
-
Neuromuscular diseases associated with COVID-19 vaccines: a systematic review and pooled analysis of 258 patients.BMC Neurol. 2023 Dec 11;23(1):437. doi: 10.1186/s12883-023-03486-y. BMC Neurol. 2023. PMID: 38082244 Free PMC article.
-
Serious neurological adverse events following immunization against SARS-CoV-2: a narrative review of the literature.Ther Adv Drug Saf. 2023 May 21;14:20420986231165674. doi: 10.1177/20420986231165674. eCollection 2023. Ther Adv Drug Saf. 2023. PMID: 37223456 Free PMC article. Review.
-
Bell's Palsy and COVID-19 Vaccines: A Systematic Review and Meta-Analysis.Vaccines (Basel). 2023 Jan 20;11(2):236. doi: 10.3390/vaccines11020236. Vaccines (Basel). 2023. PMID: 36851114 Free PMC article. Review.
References
-
- European Medicines Agency. COVID-19 vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets, 2021. Available: https://www.ema.europa.eu/en/news/covid-19-vaccine-astrazeneca-benefits-... [Accessed 8 Apr 2021].
-
- Public Assessment Report - COVID-19 Vaccine Moderna, 0.20 mg/mL dispersion for injection, 2021. Available: https://assets.publishing.service.gov.uk/government/uploads/system/uploa... [Accessed 8 Apr 2021].
-
- MHRA . Public Assessment Report COVID-19 Vaccine AstraZeneca, solution for injection in multidose container COVID-19 Vaccine (ChAdOx1-S [recombinant]), 2021. Available: https://assets.publishing.service.gov.uk/government/uploads/system/uploa... [Accessed 8 April 2021].
-
- GOV.UK . Information for UK recipients on Pfizer/BioNTech COVID-19 vaccine [Internet], 2021. Available: https://www.gov.uk/government/publications/regulatory-approval-of-pfizer... [Accessed 8 Apr 2021].
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous